exchange-traded fund was one of the session's best performers Thursday. Holding
rose 5% after its Aranesp anemia drug did not contribute to the deaths of patients in a Phase III lung cancer trial.
reported a 55% jump in first-quarter earnings from a year ago, topping Wall Street's consensus forecast. Gilead was recently higher by $3.38, or 4.3%, at $81.81. The Biotech HOLDRs ETF was adding $3.89, or 2.1%, to $186.47.
Other bundled securities tracking biotech were performing well. The
First Trust Amex Biotechnology Index
was climbing 1.4% to $25.62. The
iShares Nasdaq Biotechnology
was higher by 1.3% at $81.54.
Semiconductor-related ETFs were also among winners. Earlier,
posted a 2% rise in first-quarter profit, and the stock was adding 8%. Among other individual names,
Maxim Integrated Products
was higher by 2.7%, and
was recently up 2.3%.
Ultra Semiconductor ProShares
ETF was adding 3.3% at $77.66. The
SPDR S&P Semiconductor
ETF gained 2% to $51.78. The
ETF was recently up 1.7% to $36.20. The
iShares Goldman Sachs Semiconductor
ETF was higher by 1.3% at $64.42.
Meanwhile, ETFs tracking silver were among the day's losers. Silver futures were losing 31 cents to $13.66 an ounce. The
PowerShares DB Silver
was losing 2.4% to $26.85. The
iShares Silver Trust
was lower by 1.8% to $136.26.
Energy-related ETFs were falling as crude oil slumped in a volatile session. May oil futures were tumbling $1.40 to $61.73 a barrel
iPath Goldman Sachs Crude Oil Index
was giving back 49 cents, or 1.3%, to $36.20. The
United States Oil
ETF was lower by 66 cents, or 1.3%, to $49.48.